An interventional study of Exempt Infant Formula in VLBW - Very Low Birth Weight Infant, sponsored by Mead Johnson Nutrition. Terminated at 6 sites in United States. Open to participants aged 168 Days to 224 Days. Per ClinicalTrials.gov, last updated 2024-07-09.
Sponsored by Mead Johnson Nutrition (part of Reckitt) · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Birth Weight with a site in United States — 6 open to participants now, 6 under way, none of them phase 3. Birth Weight · United States.
Among the 32 studies in Birth Weight with a site in United States, this one is the 14th largest by enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2023, is one of 15 with no phase, and was the 26th registered.
185 studies on the registry are indexed under Birth Weight; 24 are open to participants now.
Browse Birth Weight studies →6 of the 32 studies in Birth Weight with a site in United States are open now. Recruiting first, the newest first:
University of Massachusetts, Worcester · Sites in United States
Ages 18+ · Women only
University of Tennessee · Sites in United States
Ages 1 min–6 hrs
Children's National Research Institute · Sites in United States
Ages up to 4 wk
Washington University School of Medicine · Sites in United States
Ages 14–55 · Women only · Healthy volunteers
The Hospital for Sick Children · Sites in United States, Canada
Ages 1 hrs–21 days
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 18 Birth Weight studies recruiting now, 7 (39%) set no upper age limit and 11 (61%) stop at 75 or younger; 11 take children under 18; 4 take healthy volunteers.
This study: 168 Days to 224 Days · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 1990; this study’s year is marked. 2 started in 2023.
This study's enrollment of 22 is below the median of 170 across 117 interventional studies indexed under Birth Weight.
Median enrollment 49 across the 19 interventional studies, 208 across the 13 observational. Of the 23 that completed or were terminated, 3 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 32 have an industry lead sponsor. The 10 most frequent:
This study is registered under Mead Johnson Nutrition, one of the names counted as Reckitt. Under that name alone:
Mead Johnson Nutrition is the lead sponsor of 58 studies on the registry; 1 is open to participants now.
Reckitt has 1 study filed under Birth Weight — fewer than ten, so there is no comparison to draw.
1 of the studies in Birth Weight with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06870981The Hospital for Sick ChildrenOptimizing Nutrition and Milk (Opti-NuM) Project | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 32 studies in Birth Weight with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A multi-center, single-blind, randomized, controlled, parallel-designed, prospective trial to compare growth between preterm infants fed one of three study human milk fortifiers added to human milk
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Liquid human milk fortifier to be added to human milk
Other: Exempt Infant Formula
Liquid human milk fortifier to be added to human milk
Other: Exempt Infant Formula
Liquid human milk fortifier to be added to human milk
Other: Exempt Infant Formula
Liquid human milk fortifier to be added to human milk daily
Weight gain
grams/kg/day
Time frame: Daily for 28 days
Feeding Tolerance
Achievement of full enteral feeding, incidence of (TPN, Bloody stools, Feeding interruptions, Drop in feeding volume)
Time frame: Daily for 28 days
Rate of Length and head circumference gain
cm/week
Time frame: weekly up to day 28
Total energy intake
kcal
Time frame: 28 days
Total protein intake
grams
Time frame: 28 days
Respiratory status
Incidence of Apnea, Bradycardia, Supplemental oxygen/Continuous positive airway pressure/Nasal cannulation, Mechanical ventilation
Time frame: 28 days
Incidence of NEC
Modified Bell's Staging Criteria
Time frame: Study Day 0 through 28
Incidence of sepsis - clinical symptoms
Clinical symptoms - Changes in respiration, blood pressure, body temperature, stool, blood sugar and heart rate
Time frame: Study Day 0 through 28
Incidence of sepsis - culture for pathogens
Culture for pathogens - no culture, culture-negative, culture-positive, presumed contaminant
Time frame: Study day 0 through 28
Incidence of sepsis - Antibiotic use
Antibiotic use duration - less than 5 days ; 5 days or more
Time frame: Study Day 0 through 28
Total serum CO2
less than 18 mmol/L
Time frame: Study days 0, 14, 28
Metabolic Acidosis
If CO2 \<18 mmol/L then Blood gas; Acidity (pH), Carbon dioxide, partial pressure (pCO2; torr), Bicarbonate (mmol/L); Base Excess (mmol/L)
Time frame: Study days 0, 14, 28
Ran from Jul 2023 to primary completion in May 2024, 10 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.